Literature DB >> 10869719

ATP as a peripheral mediator of pain.

S G Hamilton1, S B McMahon.   

Abstract

This article reviews the extent to which recent studies substantiate the hypothesis that ATP functions as a peripheral pain mediator. The discovery of the P2X family of ion channels (for which ATP is a ligand) and, in particular, the highly selective distribution of the P2X(3) receptor within the rat nociceptive system has inspired a variety of approaches to elucidate the potential role of ATP as a pain mediator. ATP elicits excitatory inward currents in small diameter sensory ganglion cells. These currents resemble those elicited by ATP on recombinantly expressed heteromeric P2X(2/3) channels as well as homomultimers consisting of P2X(2) and P2X(3). In vivo behavioural models have characterised the algogenic properties of ATP in normal conditions and in models of peripheral sensitisation. In humans, iontophoresis of ATP induces modest pain. In rats and humans the response is dependent on capsaicin sensitive neurons and is augmented in the presence of inflammatory mediators. Since ATP can be released in the vicinity of peripheral nociceptive terminals under a variety of conditions, there exists a purinergic chain of biological processes linking tissue damage to pain perception. The challenge remains to prove a physiological role for endogenous ATP in activating this chain of events.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10869719     DOI: 10.1016/s0165-1838(00)00137-5

Source DB:  PubMed          Journal:  J Auton Nerv Syst        ISSN: 0165-1838


  43 in total

1.  Kinetics of antagonist actions at rat P2X2/3 heteromeric receptors.

Authors:  Valeria Spelta; Lin-Hua Jiang; Annmarie Surprenant; R Alan North
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

2.  Sensitisation of gastrointestinal tract afferents.

Authors:  S B McMahon
Journal:  Gut       Date:  2004-03       Impact factor: 23.059

3.  A new function for ATP: activating cardiac sympathetic afferents during myocardial ischemia.

Authors:  Liang-Wu Fu; John C Longhurst
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-09-24       Impact factor: 4.733

Review 4.  P2X3 receptor involvement in pain states.

Authors:  Kerstin Wirkner; Beata Sperlagh; Peter Illes
Journal:  Mol Neurobiol       Date:  2007-07-17       Impact factor: 5.590

5.  Peripheral inflammation sensitizes P2X receptor-mediated responses in rat dorsal root ganglion neurons.

Authors:  Guang-Yin Xu; Li-Yen Mae Huang
Journal:  J Neurosci       Date:  2002-01-01       Impact factor: 6.167

6.  Distribution of purinergic P2X receptors in the equine digit, cervical spinal cord and dorsal root ganglia.

Authors:  D E Zamboulis; J M Senior; P D Clegg; J A Gallagher; S D Carter; P I Milner
Journal:  Purinergic Signal       Date:  2013-02-06       Impact factor: 3.765

7.  Inhibition of temporomandibular joint input to medullary dorsal horn neurons by 5HT3 receptor antagonist in female rats.

Authors:  K Okamoto; A Katagiri; M Rahman; R Thompson; D A Bereiter
Journal:  Neuroscience       Date:  2015-04-23       Impact factor: 3.590

8.  Brain-derived neurotrophic factor enhances the excitability of rat sensory neurons through activation of the p75 neurotrophin receptor and the sphingomyelin pathway.

Authors:  Y H Zhang; Xian Xuan Chi; G D Nicol
Journal:  J Physiol       Date:  2008-05-01       Impact factor: 5.182

9.  Cartilage degeneration is associated with augmented chemically-induced joint pain in rats: a pilot study.

Authors:  Meguru Okamoto; Yuji Atsuta
Journal:  Clin Orthop Relat Res       Date:  2009-12-15       Impact factor: 4.176

10.  Functional downregulation of P2X3 receptor subunit in rat sensory neurons reveals a significant role in chronic neuropathic and inflammatory pain.

Authors:  Jane Barclay; Sadhana Patel; Gabriele Dorn; Glen Wotherspoon; Sarah Moffatt; Louise Eunson; Samir Abdel'al; Francois Natt; Jonathan Hall; Janet Winter; Stuart Bevan; William Wishart; Alyson Fox; Pam Ganju
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.